Pieris Pharmaceuticals, Inc.

  • Home
  • About
  • Platform
  • Pipeline
  • Patients
  • Investors
    • Overview
    • News & Events
    • Publications
    • Presentations
    • Financial Results
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
    • Job Openings
  • Contact
Oct 30, 2007 12:00am EDT

Pieris and Pepscan to identify GPCR-specific Anticalins® using CLIPS™ protein mimicry technology

Sep 05, 2007 12:00am EDT

Pieris validates the use of Anticalins® as ophthalmologic biotherapeutics

Jul 10, 2007 12:00am EDT

Pieris progresses proprietary asthma program: validation of pulmonary delivery of Anticalin®-based protein product candidate

Jun 21, 2007 12:00am EDT

Pieris progresses development of its proprietary biotherapeutics platform: successful demonstration of dual targeting with Duocalin® technology

Mar 29, 2007 12:00am EDT

Pieris Demonstrates Potent Anti-Tumor Activity of a VEGF-Specific Anticalin® in Preclinical Studies

  • Previous
  • 1…
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
RSS
© 2023 Pieris Pharmaceuticals, Inc. All Rights Reserved.
Imprint Privacy Policy Disclaimer Sitemap Contact Us Manage Cookie Preferences